Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov;20(11):102941.
doi: 10.1016/j.autrev.2021.102941. Epub 2021 Sep 9.

Autoimmunity roots of the thrombotic events after COVID-19 vaccination

Affiliations
Review

Autoimmunity roots of the thrombotic events after COVID-19 vaccination

Fatma Elrashdy et al. Autoimmun Rev. 2021 Nov.

Abstract

Although vaccination represents the most promising way to stop or contain the coronavirus disease 2019 (COVID-19) pandemic and safety and effectiveness of available vaccines were proven, a small number of individuals who received anti-SARS-CoV-2 vaccines developed a prothrombotic syndrome. Vaccine-induced immune thrombotic thrombocytopenia (VITT) can be triggered by the adenoviral vector-based vaccine, whereas lipid nanoparticle-mRNA-based vaccines can induce rare cases of deep vein thrombosis (DVT). Although the main pathogenic mechanisms behind this rare phenomenon have not yet been identified, both host and vaccine factors might be involved, with pathology at least in part being related to the vaccine-triggered autoimmune reaction. In this review, we are considering some aspects related to pathogenesis, major risk factors, as well as peculiarities of diagnosis and treatment of this rare condition.

Keywords: Adenoviral vector-based vaccine; Autoimmune reaction; COVID-19; Lipid nanoparticle-mRNA-based vaccine; Vaccine-induced immune thrombotic thrombocytopenia.

PubMed Disclaimer

References

    1. Redwan E.M. COVID-19 pandemic and vaccination build herd immunity. Eur Rev Med Pharmacol Sci. 2021;25:577–579. doi: 10.26355/eurrev_202101_24613. - DOI - PubMed
    1. Greinacher A., Thiele T., Warkentin T.E., Weisser K., Kyrle P.A., Eichinger S. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med. 2021 doi: 10.1056/NEJMoa2104840. - DOI - PMC - PubMed
    1. Muir K.L., Kallam A., Koepsell S.A., Gundabolu K. Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination. N Engl J Med. 2021 doi: 10.1056/NEJMc2105869. - DOI - PMC - PubMed
    1. Schultz N.H., Sørvoll I.H., Michelsen A.E., Munthe L.A., Lund-Johansen F., Ahlen M.T., et al. Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. N Engl J Med. 2021 doi: 10.1056/NEJMoa2104882. - DOI - PMC - PubMed
    1. Scully M., Singh D., Lown R., Poles A., Solomon T., Levi M., et al. Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination. N Engl J Med. 2021 doi: 10.1056/NEJMoa2105385. - DOI - PMC - PubMed